SÍNTESIS RÁPIDA. Tratamiento específico de la infección por COVID 19

De
SÍNTESIS RÁPIDA. Tratamiento específico de la infección por COVID 19


Unidad de Evidencia y Deliberación para la Toma de Decisiones
25/03/2020


Autores
Marcela Vélez, MD, MsC, PhD. Profesora e Investigadora de la Fac. de Medicina, Universidad de Antioquia. Viviana Vélez, MD, MsC (c), Investigadora de la Facultad de Medicina, Universidad de Antioquia
Isabel Cristina Marín, MD, MsC (c) Investigadora de la Facultad de Medicina, Universidad de Antioquia David Castaño, MD, MsC (c), Estudiante de maestría en epidemiología clínica, Universidad de Antiquia Pamela Velásquez Salazar, MD, MsC, Investigadora de la Facultad de Medicina, Universidad de Antioquia Claudia Yaneth Vera-Giraldo, MsC, Investigadora de la Facultad de Medicina, Universidad de Antioquia Daniel Patiño, MsC, PhD. Profesor e Investigador de la Facultad de Medicina, Universidad de Antioquia Paola Andrea Ramírez, Bibliotecóloga.

Esta síntesis rápida no contiene recomendaciones, solo moviliza la evidencia de investigación global y local sobre una pregunta presentada por los tomadores de decisiones. Es de vital importancia mantener actualizada esta síntesis con la evidencia que rápidamente se está produciendo en diferentes países. El equipo de la UNED se compromete a una actualización semanal mientras se requiera la información.


Comentarios

Publicar un comentario

Entradas populares de este blog

Contact urticaria: Frequency, elicitors and cofactors in three cohorts (Information Network of Departments of Dermatology; Network of Anaphylaxis; and Department of Dermatology, University Hospital Erlangen, Germany)

De
Contact urticaria: Frequency, elicitors and cofactors in three cohorts (Information Network of Departments of Dermatology; Network of Anaphylaxis; and Department of Dermatology, University Hospital Erlangen, Germany) Authors: Helene Süß, Sabine Dölle-Bierke,  Johannes Geier, Burkhard Kreft, Eva Oppel, Claudia Pföhler, Christoph Skudlik, Margitta Worm, Vera Mahler Abstract:   Background: Contact urticaria (CU) is an infrequent, mostly occupational disease that may be life-threatening (CU syndrome stage 4). Objectives: To identify the current frequency, elicitors and cofactors of CU. Patients: Three cohorts were retrospectively analysed for CU: (a) patients from the Information Network of Departments of Dermatology (IVDK) database (2000-2014; n = 159 947); (b) patients from an allergy unit (Department of Dermatology, University Hospital Erlangen, 2000-2015; n = 4741); and (c) patients from the Anaphylaxis Registry (2007-2015: 6365 reported cases, including 2473 patients with Ring and Mes
Leer más

ICON: Diagnosis and management of allergic conjunctivitis. Miércoles 25 de marzo

De
ICON: Diagnosis and management of allergic conjunctivitis. Authors: Bielory L1, Delgado L2, Katelaris CH3, Leonardi A4, Rosario N5, Vichyanoud P6. Author information Abstract Ocular allergy (OA), interchangeably known as allergic conjunctivitis, is a common immunological hypersensitivity disorder affecting up to 40% of the population. Ocular allergy has been increasing in frequency, with symptoms of itching, redness, and swelling that significantly impacts an individual's quality of life (QOL). Ocular allergy is an often underdiagnosed and undertreated health problem, because only 10% of patients with OA symptoms seek medical attention, whereas most patients manage with over-the-counter medications and complementary nonpharmacological remedies. The clinical course, duration, severity, and co-morbidities are varied and depend, in part, on the specific ocular tissues that are affected and on immunologic mechanism(s) involved, both local and systemic. It is frequently associat
Leer más

How to Approach Chronic Inducible Urticaria

De
How to Approach Chronic Inducible Urticaria  Marcus Maurer, MDa , Joachim W. Fluhr, MDa , and David A. Khan, MDb Berlin, Germany; and Dallas, Texas  a Department of Dermatology and Allergy, Charité e Universitätsmedizin, Berlin, Germany  b Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex  Corresponding author: Marcus Maurer, MD, Department of Dermatology and Allergy, Charité e Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. E-mail: marcus.maurer@charite.de Abstract : Chronic inducible urticaria (CIndU) is a group of chronic urticarias characterized by the appearance of recurrent wheals, recurrent angioedema or both, as a response to specific triggers. CIndU includes both physical (symptomatic dermographism, cold and heat urticaria, delayed pressure urticaria, solar urticaria, and vibratory urticaria) and nonphysical urticarias (cholinergic urticaria, contact and aquage
Leer más